Nanofibrillar Structure for Cell Culture and Tissue Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell and tissue culture methods lack the spatial cues and chemical triggers present in vivo, leading to inadequate cell proliferation and differentiation, especially when cells are grown on planar surfaces, which do not accurately mimic the three-dimensional tissue environment.
Innovation Solution
A nanofibrillar structure composed of nanofibers with diameters less than 1000 nm, engineered to provide a biomimetic substratum for cell growth, incorporating lipids and bioactive molecules, and featuring a polydisperse plurality of thin fibers for enhanced cell attachment and a matrix with controlled topography and bioactive molecule distribution.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cells are grown on planar culture surfaces, then cell proliferation can be maintained, but spatial cues and chemical triggers present in vivo are lost, leading to inadequate cell differentiation and tissue-like organization
Solution Approach 1:
The patent transitions from two-dimensional planar culture surfaces to three-dimensional nanofibrillar matrices that mimic the spatial architecture of native extracellular matrix. This dimensional change restores spatial cues and chemical trigger distribution, enabling proper cell differentiation and tissue-like organization while maintaining cell proliferation capacity
Solution Approach 2:
The patent employs composite nanofibrillar structures combining biocompatible polymers with bioactive molecules and chemical triggers distributed throughout the matrix. This composite approach provides both the structural framework for cell growth and the biochemical signals necessary for differentiation, resolving the contradiction between proliferation and differentiation
2Reliability
If nanofibrillar structures with diameters less than 1000 nm are used, then cell attachment and tissue-like patterns are enhanced, but manufacturing complexity increases
Solution Approach 1:
The patent utilizes electrospinning technology to control fiber diameter parameters, producing nanofibers with diameters less than 1000 nm through adjustment of processing parameters such as voltage, flow rate, and collector distance. This parameter control enables reproduction of native ECM architecture while maintaining manufacturing feasibility
Solution Approach 2:
The patent copies the natural extracellular matrix architecture at the nanoscale by replicating the fibrillar organization and density found in vivo. This copying approach simplifies design by using nature's proven structure rather than attempting to create entirely new complex architectures
Data Source
AI summary
A nanofibrillar structure for cell culture and tissue engineering is disclosed. The nanofibrillar structure can be used in a variety of applications including methods for proliferating and/or differentiating cells and manufacturing a tissue. Also disclosed is an improved nanofiber comprising a lipid, lipophilic molecule, or chemically modified surface. The nanofibers can be used in a variety of applications including the formation of nanofibrillar structures for cell culture and tissue engineering.